Position in EBS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,651,567
-$10,000,093 QoQ
Shares Held
198,984
-78.9% QoQ
Ownership
0.388%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Jain Global LLC holds $25,027,700 across 15 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
575,860 | $19,965,066 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
82,952 | $829,520 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,298 | $703,295 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
25,379 | $624,577 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
28,770 | $516,709 | |
| 6 | HROW |
Harrow, Inc.
|
10,086 | $428,352 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
4,648 | $384,761 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
12,641 | $320,702 |
All Filings in EBS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,651,567 | 198,984 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,651,660 | 942,691 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,486,795 | 508,707 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $310,622 | 63,914 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $537,969 | 56,273 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||